Patents by Inventor Nigel A. Morrison

Nigel A. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isoforms of the human vitamin D receptor
    Patent number: 7317078
    Abstract: The invention provides isolated polynucleotide molecules which encode novel isoforms of the human Vitamin D receptor (hVDR) or variant transcripts for hVDR. These isolated polynucleotide molecules may be utilized in, for example, methods of screening compounds for VDR agonist and/or antagonist activities.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: January 8, 2008
    Assignee: Garvan Institute of Medical Research
    Inventors: Linda Anne Crofts, Manuela S. Hancock, Nigel A. Morrison, John A. Eisman
  • Isoforms of the human vitamin D receptor
    Patent number: 6998473
    Abstract: The invention provides isolated polynucleotide molecules which encode novel isoforms of the human Vitamin D receptor (hVDR) or variant transcripts for hVDR. These isolated polynucleotide molecules may be utilized in, for example, methods of screening compounds for VDR agonist and/or antagonist activities.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: February 14, 2006
    Assignee: Garvan Institute of Medical Research
    Inventors: Linda Anne Crofts, Manuela S. Hancock, Nigel A. Morrison, John A. Eisman
  • Assessment of allelic variation in vitamin D receptor correlated to bone density or turnover
    Patent number: 5593833
    Abstract: The present invention provides a genetic test for assaying predisposition to and/or resistance to high rates of bone turnover, development of low bone mass and responsiveness or otherwise to therapeutic modalities. This is a specific model for use in prediction of osteoporosis and likely response to preventive or therapeutic modalities. It is a general model of allelic variation in transcriptional regulators determining physiological set-points and thus susceptibility or resistance to certain pathophysiological states.
    Type: Grant
    Filed: March 2, 1995
    Date of Patent: January 14, 1997
    Assignee: Garvan Institute of Medical Research
    Inventors: Nigel A. Morrison, John A. Eisman, Paul J. Kelly